Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roald van der Laan

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Respiratory Research|December 24, 2022
Meeting the challenges of NTM-PD from the perspective of the organism and the disease process: innovations in drug development and deliveryRoald van der Laan, Andy Snabilié, Marko Obradovic
BMJ Open Respiratory Research|April 26, 2020
Non-tuberculous mycobacterial lung disease in patients with bronchiectasis: perceived risk, severity and guideline adherence in a European physician surveyDirk Wagner, Jakko van Ingen, Roald van der Laan, et al.
Drugs - Real World Outcomes|July 29, 2025
Nontuberculous Mycobacterial Lung Disease Management in Belgium: A Longitudinal Pharmacy Database StudyEliana Peeters, Marko Obradovic, Roald van der Laan, et al.
ERJ Open Research|May 5, 2023
Global survey of physician testing practices for nontuberculous mycobacteriaMichael R Loebinger, Roald van der Laan, Marko Obradovic, et al.
European Respiratory Review : an Official Journal of the European Respiratory Society|July 22, 2021
Liposomal drug delivery to manage nontuberculous mycobacterial pulmonary disease and other chronic lung infectionsJames D Chalmers, Jakko van Ingen, Roald van der Laan, et al.
Advances in Therapy|May 7, 2023
Eliciting Patient Insights on the Burden of Nontuberculous Mycobacterial Lung Disease (NTM-LD) and Healthcare Gaps in Germany Through Qualitative Semi-structured InterviewsChristian Hoenig, Roald van der Laan, Andreas Reimann, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|January 14, 2021
Predictive modeling of nontuberculous mycobacterial pulmonary disease epidemiology using German health claims dataFelix C Ringshausen, Raphael Ewen, Jan Multmeier, et al.
The European Respiratory Journal|May 21, 2020
Identification of potentially undiagnosed patients with nontuberculous mycobacterial lung disease using machine learning applied to primary care data in the UKOrla M Doyle, Roald van der Laan, Marko Obradovic, et al.
BMJ Open Respiratory Research|June 23, 2020
Current and future management of non-tuberculous mycobacterial pulmonary disease (NTM-PD) in the UKMarc Lipman, Joanne Cleverley, Tom Fardon, et al.
Chest|November 9, 2023
ResponseMichael R Loebinger, Jennifer K Quint, Roald van der Laan, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Respiratory Research|December 24, 2022
Meeting the challenges of NTM-PD from the perspective of the organism and the disease process: innovations in drug development and deliveryRoald van der Laan, Andy Snabilié, Marko Obradovic
BMJ Open Respiratory Research|April 26, 2020
Non-tuberculous mycobacterial lung disease in patients with bronchiectasis: perceived risk, severity and guideline adherence in a European physician surveyDirk Wagner, Jakko van Ingen, Roald van der Laan, et al.
Drugs - Real World Outcomes|July 29, 2025
Nontuberculous Mycobacterial Lung Disease Management in Belgium: A Longitudinal Pharmacy Database StudyEliana Peeters, Marko Obradovic, Roald van der Laan, et al.
ERJ Open Research|May 5, 2023
Global survey of physician testing practices for nontuberculous mycobacteriaMichael R Loebinger, Roald van der Laan, Marko Obradovic, et al.
European Respiratory Review : an Official Journal of the European Respiratory Society|July 22, 2021
Liposomal drug delivery to manage nontuberculous mycobacterial pulmonary disease and other chronic lung infectionsJames D Chalmers, Jakko van Ingen, Roald van der Laan, et al.
Advances in Therapy|May 7, 2023
Eliciting Patient Insights on the Burden of Nontuberculous Mycobacterial Lung Disease (NTM-LD) and Healthcare Gaps in Germany Through Qualitative Semi-structured InterviewsChristian Hoenig, Roald van der Laan, Andreas Reimann, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|January 14, 2021
Predictive modeling of nontuberculous mycobacterial pulmonary disease epidemiology using German health claims dataFelix C Ringshausen, Raphael Ewen, Jan Multmeier, et al.
The European Respiratory Journal|May 21, 2020
Identification of potentially undiagnosed patients with nontuberculous mycobacterial lung disease using machine learning applied to primary care data in the UKOrla M Doyle, Roald van der Laan, Marko Obradovic, et al.
BMJ Open Respiratory Research|June 23, 2020
Current and future management of non-tuberculous mycobacterial pulmonary disease (NTM-PD) in the UKMarc Lipman, Joanne Cleverley, Tom Fardon, et al.
Chest|November 9, 2023
ResponseMichael R Loebinger, Jennifer K Quint, Roald van der Laan, et al.
Pageof 2